PegBio Co., Ltd. released its Monthly Return for Equity Issuer covering the period ended 31 August 2026, showing a stable capital structure and continued compliance with Hong Kong public-float requirements.

Authorised / Registered Capital • Registered share capital stood unchanged at RMB 391.09 million, comprising 386.00 million H-shares and 5.09 million unlisted ordinary shares, each with a par value of RMB 1. • No increase or decrease in registered shares was recorded during the month.

Issued Shares and Public Float • Issued H-shares (excluding treasury shares) remained at 386.00 million; the company held no treasury shares. • Issued unlisted shares remained at 5.09 million. • PegBio confirmed that it met the Main Board Rule 13.32D(1) minimum public-float threshold of 25% as of 31 August 2026.

Capital Instruments and Corporate Actions • The company reported no movements in share options, warrants, convertible securities, or other equity-linked instruments during the month. • No repurchases, cancellations, redemptions, or treasury-share transactions occurred.

Governance • The filing was submitted on 3 September 2026 and signed by Joint Company Secretary Huang Yifeng, affirming the accuracy of the disclosed information.

Key Takeaway PegBio maintained a steady equity base throughout August 2026, with all compliance metrics—including the public-float requirement—fully satisfied and no dilution or capital changes recorded.